215 related articles for article (PubMed ID: 23743627)
21. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2).
Kim SH; Choi EY; Shin YK; Kim TJ; Chung DH; Chang SI; Kim NK; Park SH
Blood; 1998 Dec; 92(11):4287-95. PubMed ID: 9834235
[TBL] [Abstract][Full Text] [Related]
22. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
Scholz F; Schulte A; Adamski F; Hundhausen C; Mittag J; Schwarz A; Kruse ML; Proksch E; Ludwig A
J Invest Dermatol; 2007 Jun; 127(6):1444-55. PubMed ID: 17363916
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
24. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
25. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
Lee IS; Kim SH; Song HG; Park SH
Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
[TBL] [Abstract][Full Text] [Related]
26. [Expression of Septin2 in Hodgkin lymphoma cell line L428 and its role in promoting H/RS cells' redifferentiation to B lymphocytes].
Sun QC; Zhong L; Qiu B; Zhao T; Zhou XH
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):134-139. PubMed ID: 28279038
[No Abstract] [Full Text] [Related]
27. [The role of CXCL16 in immunological liver injury induced by BCG and LPS in mice].
Xu HB; Gong YP; Jiang ZG; Liu RZ; Xiong SD
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):282-5. PubMed ID: 15850518
[TBL] [Abstract][Full Text] [Related]
28. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
[TBL] [Abstract][Full Text] [Related]
30. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
31. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
[TBL] [Abstract][Full Text] [Related]
32. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.
Schramme A; Abdel-Bakky MS; Kämpfer-Kolb N; Pfeilschifter J; Gutwein P
Biochem Biophys Res Commun; 2008 May; 370(2):311-6. PubMed ID: 18373975
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
[TBL] [Abstract][Full Text] [Related]
34. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
35. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
Cattaruzza L; Gloghini A; Olivo K; Di Francia R; Lorenzon D; De Filippi R; Carbone A; Colombatti A; Pinto A; Aldinucci D
Int J Cancer; 2009 Sep; 125(5):1092-101. PubMed ID: 19391137
[TBL] [Abstract][Full Text] [Related]
36. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
37. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
39. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
40. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
